System Messages

Recursos de información sobre inmunidad y SARS-CoV-2

La Sociedad Cubana de Inmunología apoya la lucha internacional contra la pandemia de la COVID-19, y presenta una relación de recursos de información relacionados con la respuesta inmune al SARS-CoV-2.

Los más de 150 artículos seleccionados están disponibles a texto completo, y han sido publicados desde el 1º de marzo de 2020.

168. Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis. BMJ 2020;370:m2516.
167. Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling. J Exp Med 7 December 2020;217(12):e20201241.
166. A Potently Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection. J Immunol August 15, 2020;205(4)915-922.
165. A Case for Targeting Th17 Cells and IL-17A in SARS-CoV-2 Infections. J Immunol August 15, 2020;205(4)892-898.
164. Immune Response, Inflammation, and the Clinical Spectrum of COVID-19. Front. Immunol., 16 June 2020;
163. Demand for BCG Vaccine Due to Unproven Claims of its Role in Preventing COVID-19 Is Causing Shortages of Vaccines for Infants in Japan. Pediatr Infect Dis J. 2020 Jul;39(7):e159–e160.
162. Abnormal immunity of non-survivors with COVID-19: predictors for mortality. Infect Dis Poverty. 2020;9:108.
161. Comparison of different serological assays for SARS-CoV-2 in real life. J Clin Virol. 2020 Aug 2:104569; doi: 10.1016/j.jcv.2020.104569.
160. Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2. J Clin Virol. 2020 Aug 2:104572; doi: 10.1016/j.jcv.2020.104572.
159. The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions. Med Hypotheses. 2020 Aug 2:110155; doi: 10.1016/j.mehy.2020.110155.
158. Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19. Rheumatol Int. 2020 Aug 2:1–11; doi: 10.1007/s00296-020-04663-9.
157. Anaphylactic shock following diagnosis of COVID-19. Ann Allergy Asthma Immunol. 2020 Aug 1; doi: 10.1016/j.anai.2020.07.032.
156. Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies. Biomed Pharmacother. 2020 Aug 1:110559; doi: 10.1016/j.biopha.2020.110559
155. Establishing a Unified COVID-19 “Immunome”: Integrating Coronavirus Pathogenesis and Host Immunopathology. Frontiers in Immunology, 2020;11:1642.
154. SCHOOL of nature: ligand-independent immunomodulatory peptides. Drug Discov Today. 2020 May 12; doi: 10.1016/j.drudis.2020.05.005
153. Metformin Enhances Autophagy and Normalizes Mitochondrial Function to Alleviate Aging-Associated Inflammation. Cell Metab. 2020 May 12; doi: 10.1016/j.cmet.2020.04.015
152. CD4+ T Cells at the Center of Inflammaging. Cell Metab. 2020 May 12; doi: 10.1016/j.cmet.2020.04.016
151. Convalescent plasma: A possible treatment protocol for COVID- 19 patients suffering from diabetes or underlying liver diseases. Diabetes Metab Syndr. 2020 May 12; doi: 10.1016/j.dsx.2020.05.023
150. Mechanism of inflammatory response in associated comorbidities in COVID-19. Diabetes Metab Syndr. 2020 May 12; doi: 10.1016/j.dsx.2020.05.025
149. Is aberrant CD8+ T cell activation by hypertension associated with cardiac injury in severe cases of COVID-19? Cell Mol Immunol. 2020 May 12:1–2; doi: 10.1038/s41423-020-0454-3

Vea la relación completa en el sitio web de Inmunología.

Palabras clave: inmunología, SARS-CoV-2, COVID-19, recursos de información, artículos, Sociedad Cubana